Results 201 to 210 of about 91,203 (305)

Associations Between Diabetic Neuropathy and Balance Impairments in Patients with Type 2 Diabetes: A Cross-Sectional Study. [PDF]

J Clin Med
Iliescu B, Herascu A, Gaita L, Avram VF, Timar B.   +4 more
europepmc   +1 more source

Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo‐Neo T2DM study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This real‐world study evaluated the effectiveness and safety of switching basal insulin (BI) to insulin glargine 300 U/mL (Gla‐300) in adults with inadequately controlled type 2 diabetes mellitus (T2DM), previously receiving basal‐supported oral therapy plus prandial insulin (BOTplus) or multiple (≥3) daily injections (MDI) of short ...
Stefan Pscherer, Andreas Fritsche, Helmut Anderten, Katrin Pegelow, Henry Y. Han, Martin Pfohl, Jochen Seufert   +6 more
wiley   +1 more source

Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: A post‐hoc analysis of the INITIATION study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the glycaemic outcomes and safety of insulin glargine 300 U/mL (Gla‐300) in Chinese people with uncontrolled type 2 diabetes (T2D) by baseline age and disease duration. Materials and Methods INITIATION was a 24‐week, interventional, single‐arm study where adults with T2D (glycated haemoglobin [HbA1c] 7.5%–11.0%) received Gla ...
Liming Chen, Qiu Zhang, Binhong Duan, Xiaohong Wu, Hailong Wan, Binhong Wen, Jie Han, Haixia Liu, Caixian Yang, Weiwei Liu, Qin Du, Lei Kang, Minlu Zhang   +12 more
wiley   +1 more source

Neuroactive Kynurenine Metabolite Alterations Unveil Novel Association to Locomotor Deterioration in Diabetic Neuropathy. [PDF]

Int J Tryptophan Res
Perez-Alvarez A, Salazar V, Bruges G, Vonasek E, Eblen-Zajjur A.   +4 more
europepmc   +1 more source

Independent associations of mental health and diabetes complications with health‐related quality of life: Evidence from a cross‐sectional study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Health‐related quality of life (HRQoL) is a key patient‐reported outcome in diabetes care, yet the extent to which somatic and psychological factors are associated with HRQoL remains unclear. This study examined how demographic, diabetes‐related, medical, and psychological factors were independently associated with HRQoL in adults with ...
Norbert Hermanns, Philip Kittel, Paco Cerletti, Bernhard Kulzer, Dominic Ehrmann   +4 more
wiley   +1 more source

Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub-Saharan African Cohort. [PDF]

J Peripher Nerv Syst
Chokote SE, Lemdjo G, Idiaquez Rios JF, Anakeu AT, Ngarka L, Nfor LN, Mengnjo MK, Njamnshi WY, Kengni HNT, Ngongang RJ, Simeni G, Piameu L, Nkonda AB, Yepnjio F, Tatah GY, Thirugnanam UN, Njamnshi AK.   +16 more
europepmc   +1 more source

Assessment of subclinical LV myocardial dysfunction in T2DM patients with diabetic peripheral neuropathy: a cardiovascular magnetic resonance study [PDF]

Xueming Li, Ke Shi, Jiang Li, Jing Wang, Wei‐Feng Yan, Yue Gao, Mengting Shen, Rui Shi, Ge Zhang, Xiaojing Liu, Yingkun Guo, Zhi‐gang Yang   +11 more
openalex   +1 more source

Once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes in China: A cost‐utility and budget impact analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Insulin icodec, the first once‐weekly basal insulin analogue, was approved in China in 2024. Although it has demonstrated robust clinical efficacy, its budget impact remains unknown, and the long‐term cost‐utility within the reimbursement context needs further estimates.
Xichen Tong, Yawen Zhang, Lei Zhang, Luying Zhang   +3 more
wiley   +1 more source

Short-term spinal cord stimulation for refractory Elsberg syndrome in diabetic neuropathy: A case report. [PDF]

World J Clin Cases
Wang J, Yu XQ, Zhang XG, Song L, Lee J.
europepmc   +1 more source

A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Glucocorticoids (GCs) are widely utilised for the treatment of inflammatory and autoimmune conditions but often precipitate significant hyperglycaemia. People with type 1 diabetes (PWT1D) may be particularly affected due to the challenges of adjusting insulin dosing, for which recommendations remain unclear.
Alexandra Katz, Aidan Shulkin, Asmaa Housni, Amélie Roy‐Fleming, Rémi Rabasa‐Lhoret, Jean‐Francois Yale, Michael A. Tsoukas, Tricia M. Peters, Anne‐Sophie Brazeau   +8 more
wiley   +1 more source